{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:53Z","timestamp":1792785713614,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health and Family Welfare, New Delhi, India","award":["V.25011\/458-HRD\/2016-HR"],"award-info":[{"award-number":["V.25011\/458-HRD\/2016-HR"]}],"id":[{"id":"https:\/\/ror.org\/04pqetg36","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Biotechnology New Delhi, India","id":[{"id":"https:\/\/ror.org\/03tjsyq23","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of Delhi, Delhi, India","id":[{"id":"https:\/\/ror.org\/04gzb2213","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009706","name":"EU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejmech.2018.07.019","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:03:40Z","timestamp":1531141420000},"page":"430-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in\u00a0vitro and in\u00a0vivo appraisal"],"prefix":"10.1016","volume":"156","author":[{"given":"Chandra Bhushan","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Buonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.07.019_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2018.07.019_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development","volume":"12","author":"Loscher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.019_bib3","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.2174\/1381612822666160226144200","article-title":"Polypharmacological drugs in the treatment of epilepsy: the comprehensive review of marketed and new emerging molecules","volume":"22","author":"Kumari","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.07.019_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"Loscher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2018.07.019_bib5a","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0920-1211(02)00019-0","article-title":"Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in\u00a0vivo","volume":"49","author":"Aribi","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib5b","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1073\/pnas.89.16.7786","article-title":"pH transients evoked by excitatory synaptic transmission are increased by inhibition of extracellular carbonic anhydrase","volume":"89","author":"Chen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.07.019_bib5c","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1523\/JNEUROSCI.20-04-01290.2000","article-title":"Activity-dependent intracellular acidification correlates with the duration of seizure activity","volume":"20","author":"Xiong","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2018.07.019_bib5d","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(98)00341-2","article-title":"CO2\/HCO3(-)-withdrawal from the bath medium of hippocampal slices: biphasic effect on intracellular pH and bioelectric activity of CA3-neurons","volume":"796","author":"Bonnet","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib6a","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0960-894X(03)00029-5","article-title":"Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates\/sulfamides with isozymes I, II and IV","volume":"13","author":"Casini","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib6b","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1039\/C6OB00803H","article-title":"The anticonvulsant sulfamide JNJ-26990990 and its S, S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies","volume":"14","author":"Di Fiore","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib6c","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2016.1154534","article-title":"Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2016","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib7a","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.07.019_bib7b","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.019_bib7c","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature10464","article-title":"Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon","volume":"478","author":"Smeulders","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.07.019_bib8a","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1233692","article-title":"Root effect hemoglobin may have evolved to enhance general tissue oxygen delivery","volume":"340","author":"Rummer","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.07.019_bib8b","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnologic use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib8c","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumors as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.019_bib8d","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.07.019_bib9a","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/14756366.2016.1197221","article-title":"Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl\/1,3,4-thiadiazol-2-yl)-4-(3 substituted phenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors","volume":"31","author":"Mishra","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib9b","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib9c","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bmc.2012.05.053","article-title":"Carbonic anhydrase regulation and CO2 sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog","volume":"21","author":"Cottier","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib9d","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jmb.2008.11.037","article-title":"Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans","volume":"385","author":"Schlicker","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib10a","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0300-9084(78)80206-5","article-title":"Anhydrase carbonique du syst\u00e8me nerveux central du rat, Isolement et proprietes","volume":"60","author":"Filippi","year":"1978","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2018.07.019_bib10b","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(95)00026-M","article-title":"On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain","volume":"676","author":"Agnati","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib11","series-title":"The Carbonic Anhydrases: New Horizons","first-page":"79","article-title":"An overview of the distribution and function of carbonic anhydrase in mammals","author":"Parkkila","year":"2000"},{"key":"10.1016\/j.ejmech.2018.07.019_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuint.2005.08.007","article-title":"Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus","volume":"48","author":"Halmi","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2018.07.019_bib13a","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/brain\/106.1.55","article-title":"The enzyme histochemistry of the choroid plexus","volume":"106","author":"Masuzawa","year":"1983","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2018.07.019_bib13b","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0165-3806(93)90200-T","article-title":"Developmental changes in seizure susceptibility in carbonic anhydrase II-deficient mice and normal littermates","volume":"72","author":"Velisek","year":"1993","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib13c","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1747-0285.2009.00857.x","article-title":"Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?","volume":"74","author":"De Simone","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.07.019_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/002215549704500503","article-title":"Differential expression of the carbonic anhydrase genes for CA VII (Car7) and CA-RP VIII (Car8) in mouse brain","volume":"45","author":"Lakkis","year":"1997","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib15a","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","first-page":"271","article-title":"Carbonic anhydrases and brain pH in the control of neuronal excitability","author":"Ruusuvuori","year":"2014"},{"key":"10.1016\/j.ejmech.2018.07.019_bib15b","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/emboj.2013.160","article-title":"Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures","volume":"32","author":"Ruusuvuori","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2018.07.019_bib16a","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1523\/JNEUROSCI.5176-03.2004","article-title":"Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells","volume":"24","author":"Ruusuvuori","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2018.07.019_bib16b","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.2004.077495","article-title":"Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII","volume":"562","author":"Rivera","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib16c","series-title":"Carbonic Anhydrase: its Inhibitors and Activators","first-page":"25","article-title":"A\u00a0catalytic CAs: carbonic anhydrase related proteins","author":"Nishimori","year":"2004"},{"key":"10.1016\/j.ejmech.2018.07.019_bib17a","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00010.2003","article-title":"Regulation and modulation of pH in the brain","volume":"83","author":"Chesler","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2018.07.019_bib17b","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrm2820","article-title":"Sensors and regulators of intracellular pH","volume":"11","author":"Casey","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib17c","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1523\/JNEUROSCI.3355-10.2010","article-title":"Spontaneous network events driven by depolarizing GABA action in neonatal hippocampal slices are not attributable to deficient mitochondrial energy metabolism","volume":"30","author":"Ruusuvuori","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2018.07.019_bib17d","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1748-1716.1993.tb09553.x","article-title":"Intracellular carbonic anhydrase activity and its role in GABA-induced acidosis in isolated rat hippocampal pyramidal neurons","volume":"148","author":"Pasternack","year":"1993","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejmech.2018.07.019_bib17e","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1073\/pnas.0702676104","article-title":"Control of hypothalamic orexin neurons by acid and CO2","volume":"104","author":"Williams","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.07.019_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001756-199301000-00024","article-title":"Intrinsic proton modulation of excitatory transmission in rat hippocampal slices","volume":"4","author":"Taira","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejmech.2018.07.019_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1113\/jphysiol.1994.sp020258","article-title":"Endogenous H+ modulation of NMDA receptor mediated EPSCs revealed by carbonic anhydrase inhibition in rat hippocampus","volume":"478","author":"Gottfried","year":"1994","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib20a","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/106002809603000515","article-title":"Acetazolamide in the treatment of seizures","volume":"30","author":"Reiss","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.07.019_bib20b","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0387-7604(02)00003-7","article-title":"Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies","volume":"24","author":"Katayama","year":"2002","journal-title":"Brain Dev."},{"key":"10.1016\/j.ejmech.2018.07.019_bib20c","series-title":"Carbonic Anhydrase: its Inhibitors and Activators","first-page":"283","article-title":"Role of carbonic anhydrase and its inhibitors in gastroenterology, neurology and nephrology","author":"Parkkila","year":"2004"},{"key":"10.1016\/j.ejmech.2018.07.019_bib21a","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.seizure.2004.04.016","article-title":"Zonisamide: chemistry, mechanism of action, and pharmacokinetics","volume":"13","author":"Leppik","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.ejmech.2018.07.019_bib21b","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-1211(00)00171-6","article-title":"Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)","volume":"43","author":"Bialer","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib21c","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00171-X","article-title":"Two new actions of topiramate: inhibition of depolarizing GABA (A)-mediated responses and activation of a potassium conductance","volume":"42","author":"Herrero","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.07.019_bib22a","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.bmc.2004.03.008","article-title":"Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity","volume":"12","author":"Ilies","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib22b","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705850","article-title":"Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-\/HCO3- exchange","volume":"142","author":"Leniger","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib23","series-title":"Carbonic Anhyrdase in the Nervous System. The Carbonic Anhydrases New Horizons","first-page":"475","author":"Cammer","year":"2000"},{"key":"10.1016\/j.ejmech.2018.07.019_bib24a","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1107\/S0907444913007208","article-title":"X-ray structure of the first extremo-\u03b1-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1","volume":"69","author":"Di Fiore","year":"2013","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.07.019_bib24b","first-page":"618","article-title":"X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes","volume":"62","author":"Fisher","year":"2006","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2018.07.019_bib25a","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmc.2016.06.005","article-title":"Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6 dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors","volume":"24","author":"Vullo","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib25b","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bmcl.2015.02.068","article-title":"Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense","volume":"25","author":"De Simone","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.019_bib27a","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bmc.2012.06.053","article-title":"Effect of sulfonamides as selective carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion","volume":"21","author":"Arechederra","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib27b","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib27c","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib28a","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/13543776.2012.707646","article-title":"Update on carbonic anhydrase inhibitors: a patent review, (2008-2011)","volume":"22","author":"Aggarwal","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib28b","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib28c","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138161208783877956","article-title":"Anticonvulsant sulfonamides\/sulfamates\/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action","volume":"14","author":"Thiry","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.07.019_bib28d","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/14756366.2011.597749","article-title":"A\u00a0new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties, Mechanism of action and preliminary pharmacology","volume":"27","author":"Fabrizi","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib29a","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/156802607780636726","article-title":"Carbonic anhydrase inhibitors as anticonvulsant agents","volume":"7","author":"Thiry","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib29b","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/13543776.2012.649006","article-title":"Novel therapies for glaucoma: a patent review 2007-2011","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib29c","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005-2013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib30a","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/j.bmc.2017.06.054","article-title":"1, 3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: potency is supported by X-ray crystallography of two leads","volume":"25","author":"Ferraroni","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib30b","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.bmc.2017.05.029","article-title":"Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases","volume":"25","author":"Karal","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib30c","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib30d","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.bmc.2017.03.054","article-title":"Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib30e","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib31a","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s11064-017-2216-x","article-title":"Design and comparative evaluation of the anticonvulsant profile, carbonic-anhydrase inhibition and teratogenicity of novel carbamate derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide","volume":"42","author":"Bibi","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib31b","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cmdc.201500596","article-title":"In\u00a0vivo evaluation of selective carbonic anhydrase inhibitors as potential anticonvulsant agents","volume":"11","author":"Bruno","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.07.019_bib31c","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/jm200209n","article-title":"Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV","volume":"54","author":"Hen","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib32a","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib32b","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.07.019_bib33a","first-page":"1","article-title":"Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4, 5-dihydro-pyrazol-1-yl]benzenesulfonamides","volume":"23","author":"Gul","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib33b","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2016.1181627","article-title":"Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides","volume":"19","author":"Mete","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib33c","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1016\/j.bmc.2016.06.052","article-title":"Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]- benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties","volume":"24","author":"Bozdag","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib34a","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.bmc.2016.05.016","article-title":"Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines","volume":"24","author":"Abdel Gawad","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib34b","first-page":"1","article-title":"Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases","volume":"24","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib34c","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib34d","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2016.01.030","article-title":"Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII","volume":"110","author":"Eldehna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib34e","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bmc.2016.01.019","article-title":"Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111","volume":"24","author":"Lomelino","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib35a","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.jmedchem.5b01771","article-title":"4-Arylbenzenesulfonamides as human carbonic anhydrase Inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki\u2212Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies","volume":"59","author":"Cornelio","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib35b","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/acs.jmedchem.5b01144","article-title":"Discovery of 1, 1\u2032-biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors","volume":"58","author":"La Regina","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib35c","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1021\/acs.jmedchem.5b01228","article-title":"Phosphate chemical probes designed for location specific inhibition of intracellular carbonic anhydrases","volume":"58","author":"Rankin","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib35d","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/jm701426t","article-title":"Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides","volume":"51","author":"Wilkinson","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib35e","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/jm001051+","article-title":"Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects","volume":"43","author":"Casini","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib36a","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1021\/jm501497m","article-title":"A\u00a0class of 4-sulfamoylphenyl-\u03c9-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects","volume":"57","author":"Bozdag","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib36b","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1021\/jm049692i","article-title":"Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library","volume":"47","author":"Innocenti","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib36c","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib37a","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1016\/j.bmcl.2013.08.019","article-title":"Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII","volume":"23","author":"Biswas","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib37b","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.bmc.2015.05.013","article-title":"New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies","volume":"23","author":"Carradori","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib37c","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/j.bmc.2014.06.003","article-title":"Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies","volume":"22","author":"DAscenzio","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib37d","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.bmc.2017.08.047","article-title":"Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors","volume":"25","author":"Angapelly","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib37e","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.jmedchem.6b01804","article-title":"Discovery of benzenesulfonamides with potent human carbonic anhydrase inhibitory and effective anticonvulsant action: design, synthesis, and pharmacological assessment","volume":"60","author":"Mishra","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib38","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib39a","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejmech.2015.07.026","article-title":"M.M. Alam., Piperazine scaffold: a remarkable tool in generation of diverse pharmacological agents","volume":"102","author":"Shaquiquzzaman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib39b","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.12.031","article-title":"Thiazole: a promising heterocycle for the development of potent CNS active agents","volume":"92","author":"Mishra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib40a","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.bmc.2016.06.027","article-title":"Novel indadinone derivatives as multitarget-directed agent with cholinesterase inhibition, anti-\u03b2-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease","volume":"24","author":"Mishra","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib40b","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12272-016-0720-1","article-title":"Design and synthesis of some new 1-phenyl-3\/4-[4-(aryl\/heteroaryl\/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents","volume":"39","author":"Mishra","year":"2016","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2018.07.019_bib40c","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejmech.2016.09.057","article-title":"Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"125","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib40d","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pharep.2015.08.013","article-title":"Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent","volume":"68","author":"Kumari","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2018.07.019_bib40e","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bmcl.2015.01.004","article-title":"Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl\/aryl\/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents","volume":"25","author":"Kumari","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.07.019_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/13543776.2016.1189902","article-title":"Piperazine derivatives for therapeutic use: a patent review (2010-present)","volume":"26","author":"Rathi","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.07.019_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/14756366.2018.1437155","article-title":"Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents","volume":"3","author":"Marcinkowska","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.07.019_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.07.019_bib44","doi-asserted-by":"crossref","first-page":"W201","DOI":"10.1093\/nar\/gkv353","article-title":"FAF-Drugs 3: a web server for compound property calculation and chemical library design","volume":"43","author":"Lagorce","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eplepsyres.2005.09.012","article-title":"Molecular targets versus models for new antiepileptic drug discovery","volume":"68","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2018.07.019_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1358\/mf.2009.31.2.1338414","article-title":"The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs","volume":"31","author":"Branco","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.07.019_bib47a","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant-aminobutyric acid type A (GABAA) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.07.019_bib47b","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418305750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418305750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T13:29:02Z","timestamp":1751722142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418305750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":113,"alternative-id":["S0223523418305750"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.019","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in\u00a0vitro and in\u00a0vivo appraisal","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}